NCT04991207View on ClinicalTrials.gov

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 6, 2018

Primary Completion Date

May 14, 2018

Study Completion Date

May 14, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

BIA 5-1058

Oral BIA 5-1058 (Zamicastat) 100 mg tablets

DRUG

bosentan

Oral Tracleer (bosentan) 125 mg film coated tablets

Trial Locations (1)

14050

PAREXEL International - Early Phase Clinical Unit - Berlin, Berlin

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT04991207 - Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan | Biotech Hunter | Biotech Hunter